Variety : Actualité Variety en direct - P8 | Bourse Reflex
Accueil > Tags > Variety

  • Toutes les actualités en rapport avec « Variety »

03/05 09:30 Variety - Greenlight Re Announces First Quarter 2011 Financial Results

02/05 15:45 Variety - Greenlight Re Promotes Bart Hedges to CEO

02/05 15:20 Variety - Len Goldberg to Retire as CEO of Greenlight Re

28/04 16:10 Variety - Apricus Biosciences Requests Approval of Vitaros(R) as a Treatment for Erectile Dysfunction in Europe

28/04 11:05 Variety - Apricus Biosciences Requests Approval of Vitaros(R) as a Treatment for Erectile Dysfunction in Europe

28/04 09:30 Variety - Apricus Biosciences to Present at the FSX Investor Conference in San Francisco on April 28, 2011

28/04 09:30 Variety - Greenlight Capital Re to Release First Quarter 2011 Results

22/04 09:00 Variety - Cereplast Launches New Symbol to Represent Bioplastics

15/04 11:20 Variety - NASDAQ OMX Appoints Lee Shavel as Chief Financial Officer and Executive Vice President of Corporate Strategy

13/04 19:45 Variety - Apricus Biosciences Files for Orphan Drug Designation for RayVa(TM)

05/04 18:55 Variety - Apricus Biosciences' CEO Interviewed by WallStreetCorner.com

31/03 16:45 Variety - Apricus Biosciences Expands Patent Coverage in Mexico for Its Erectile Dysfunction Drug, Vitaros(R)

24/03 15:55 Variety - Apricus Biosciences Adopts Shareholder Rights Plan

23/03 09:15 Variety - OPNET APM Xpert(TM) Solutions Receive Accolades From Enterprise Management Associates

22/03 14:55 Variety - Apricus Biosciences Announces Poster Presentations on Progress of PrevOnco(TM) in Combination With NexACT(R) Technology at the American Association for Cancer Research 2011 Annual Meeting

15/03 15:30 Variety - Apricus Biosciences Announces Formation of Clinical Advisory Board as Part of Its Plans to Further the Clinical Development of Femprox(R)

10/03 16:00 Variety - Apricus Biosciences to Present at the Bio-Europe Spring 2011 Conference

08/03 16:00 Variety - Apricus Biosciences Announces Removal of Auditor's "Going Concern" Opinion From Its 2010 Form 10-K and Increased Cash Reserves

08/03 09:00 Variety - Hemispherx Biopharma Announces 9th Clinical Investigators Conference: Ampligen Clinical Trials Highlighted

01/03 15:15 Variety - Apricus Biosciences Announces Expanded European Patent Coverage for MycoVa(TM) for Nail Fungus